TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)
TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)
Recruiting · NCT07284277 · Registry updated 2025-12-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-12-16 | NCT07284277 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Clinica Universidad de Navarra, Universidad de Navarra | 41 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clínica Universidad de Navarra | Pamplona | Spain | 16 |
| Fundación Jiménez-Díaz | Madrid | Spain | 1 |
| Hospital de Galdakao | Galdakao | Spain | 2 |
| Hospital Universitario de Araba | Vitoria-Gasteiz | Spain | 1 |
| Hospital Universitario de Cruces | Barakaldo | Spain | 7 |